| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |